Lieu Hsiao D 4
4 · NGM BIOPHARMACEUTICALS INC · Filed Jan 18, 2024
Insider Transaction Report
Form 4
Lieu Hsiao
SVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-01-16$1.34/sh−5,430$7,276→ 54,254 total
Footnotes (2)
- [F1]Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.
- [F2]Includes 3,717 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on May 15, 2023 and 362 ESPP shares acquired on November 15, 2023.